Literature DB >> 6201595

The influence of disease activity on the number of blood cells of multiple sclerosis patients.

U Patzold, U Wurster, K Mardt, M Schiemann.   

Abstract

The influence of disease activity on blood cell counts was studied in over 100 multiple sclerosis patients examined at regular intervals of 4-8 weeks over an 18-month period. T-lymphocytes were assessed by the cytochemical alpha-naphthyl-acetate-esterase (ANAE) stain in addition to conventional differentials. In all patients as a group as well as in individual patients studied sequentially, an exacerbation was marked by a striking reduction in both the relative and absolute numbers of ANAE-positive cells. Simultaneously, a strong increase in granulocytes and a slight augmentation of ANAE-negative cells occurred. Similar changes related to disease activity in leucocytes and lymphocytes were also detected in conventional blood smears. Fluctuations in the number of blood cells with disease activity persisted under therapy with corticosteroids and to a lesser degree also with azathioprine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201595     DOI: 10.1007/bf00313648

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Multiple sclerosis. T lymphocytes in cerebrospinal fluid and blood.

Authors:  A Naess; H Nyland
Journal:  Eur Neurol       Date:  1978       Impact factor: 1.710

3.  Modulation of T-lymphocyte differentiation antigens: potential relevance for multiple sclerosis.

Authors:  J Antel; J J Oger; S Jackevicius; H H Kuo; B G Arnason
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

4.  Lymphocyte subpopulations in the cerebrospinal fluid and peripheral blood in multiple sclerosis.

Authors:  A Członkowska; M Półtorak; W Cendrowski; J Korlak
Journal:  Acta Neurol Scand       Date:  1980-07       Impact factor: 3.209

5.  Relationship of Fc-IgG and Fc-IgM receptors to the antigens defined by OKT-antibodies and the acid alpha-naphthyl-acetate-esterase spot within human T cells.

Authors:  W J Pichler; M L Lange; C Birke; H H Peter
Journal:  Immunobiology       Date:  1982-02       Impact factor: 3.144

6.  Exacerbations, activity, and progression in multiple sclerosis.

Authors:  C M Poser
Journal:  Arch Neurol       Date:  1980-08

7.  Azathioprine in treatment of multiple sclerosis. Final results of a 41/2-year controlled study of its effectiveness covering 115 patients.

Authors:  U Patzold; H Hecker; P Pocklington
Journal:  J Neurol Sci       Date:  1982-06       Impact factor: 3.181

8.  Lymphocytes in multiple sclerosis: correlation with CSF immunoglobulins and cold-reactive lymphocytotoxic antibodies.

Authors:  H L Weiner; A L Schocket
Journal:  Neurology       Date:  1979-11       Impact factor: 9.910

9.  Lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in multiple sclerosis.

Authors:  P E Manconi; M G Marrosu; C Cianchetti; M G Ennas; A Mangoni; D Zaccheo
Journal:  Acta Neurol Scand       Date:  1980-09       Impact factor: 3.209

10.  Suppressor cell activity in multiple sclerosis.

Authors:  W C Wallen; S A Houff; M Iivanainen; V P Calabrese; G H DeVries
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

View more
  1 in total

1.  T-lymphocyte subsets modifications in multiple sclerosis: correlation with clinical disease activity.

Authors:  M Prencipe; E Salerni; C D'Aurizio; C Marini; D Adorno; A M Berghella; P Pellegrini; F Papola; C U Casciani
Journal:  Ital J Neurol Sci       Date:  1986-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.